| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:88889082:4152 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:88889082:4152?format=raw |
LEADER: 04152mam a2200469 a 4500
001 4068512
005 20221027030705.0
008 020123t20022002njua b 001 0 eng c
010 $a 2002017200
015 $aGBA2-X8674
016 7 $a101136583$2DNLM
020 $a1588290263 (alk. paper)
035 $a(OCoLC)ocm48917954
035 $9AUT5185HS
035 $a(NNC)4068512
035 $a4068512
040 $aDNLM/DLC$cDLC$dNLM$dUKM$dC#P$dNNC-M$dOrLoB-B
042 $apcc
050 00 $aQH434$b.P384 2002
060 10 $aQH 307.2$bP297 2002
082 00 $a579/.165$221
245 00 $aPathogen genomics :$bimpact on human health /$cedited by Karen Joy Shaw.
260 $aTotowa, N.J. :$bHumana Press,$c[2002], ©2002.
300 $axv, 309 pages :$billustrations (some color) ;$c26 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aInfectious disease
504 $aIncludes bibliographical references and index.
505 00 $g1.$tAntiviral Drug Target Discovery with DNA Microarrays /$rKlaus Fruh and Peter Ghazal --$g2.$tChipping Away at HIV Pathogenesis /$rSteffney Elise Rought, Roman Sasik and Davey Mitchell Smith /$r[et al.] --$g3.$tMicroarray Analysis of Human Papillomavirus Pathogenesis /$rYijan Elaine Chang and Laimonis A. Laimins --$g4.$tRibozymes as Gene Therapeutic Agents for HIV/AIDS: A Potential Paradigm Shift /$rGregory C. Fanning, Janet L. Macpherson and Geoff Symonds --$g5.$tGenomics and New Technologies Applied to Antibacterial Drug Discovery /$rDonald T. Moir --$g6.$tGenomics of the Mycobacterium tuberculosis Complex and BCG Vaccines /$rMarcel A. Behr and Stephen V. Gordon --$g7.$tBacterial "Genes-to-Screens" in the Post-Genomic Era /$rMichael J. Pucci, John F. Barrett and Thomas J. Dougherty --$g8.$tDNA Microarray Expression Analysis in Antibacterial Drug Discovery /$rBrian J. Morrow and Karen Joy Shaw --
505 80 $g9.$tThe Influence of Genomics on the Molecular Epidemiology of Nosocomial Pathogens /$rRichard V. Goering --$g10.$tBorrelia Genomics as a Tool for Studying Pathogenesis and Vaccine Development /$rAlireza Shamaei-Tousi and Sven Bergstrom --$g11.$tAntifungal Target Discovery and Evaluation: Lessons from Saccharomyces cerevisiae /$rBeth DiDomenico and Scott S. Walker --$g12.$tAntifungal Drug Discovery: Old Drugs, New Tools /$rMarianne D. De Backer, Walter H. M. L. Luyten and Hugo F. Vanden Bossche --$g13.$tCryptococcus neoformans: A Molecular Model for the Study of Fungal Pathogenesis and Drug Discovery in the Genomic Era /$rJennifer K. Lodge and John R. Perfect --$g14.$tAntifungal Target Selection in Aspergillus nidulans: Using Bioinformatics to Make the Difference /$rRosanna Pena-Muralla, Patricia Ayoubi and Marcia Graminha /$r[et al.] --$g15.$tFunctional Genomics of Histoplasma capsulatum: Dimorphism and Virulence /$rGlenmore Shearer, Jr. --
505 80 $g16.$tGene Finding in Coccidioides immitis: Searching for Immunogenic Proteins /$rTheo N. Kirkland and Garry T. Cole --$g17.$tToxoplasma gondii: A Model for Evolutionary Genomics and Chemotherapy /$rJessica C. Kissinger, Michael J. Crawford and David S. Roos /$r[et al.] --$g18.$tThe Molecular Biology and Pathogenicity of Entamoeba histolytica /$rBarbara J. Mann and Brendan J. Loftus.
650 0 $aMicrobial genetics.$0http://id.loc.gov/authorities/subjects/sh85084760
650 0 $aGene expression.$0http://id.loc.gov/authorities/subjects/sh85053734
650 0 $aFungal gene expression.$0http://id.loc.gov/authorities/subjects/sh92001544
650 0 $aDNA microarrays.$0http://id.loc.gov/authorities/subjects/sh99000707
650 0 $aPathogenic microorganisms.$0http://id.loc.gov/authorities/subjects/sh85084744
650 0 $aGenomics.$0http://id.loc.gov/authorities/subjects/sh2002000809
650 12 $aMicrobiological Phenomena$xgenetics.$0https://id.nlm.nih.gov/mesh/D008827Q000235
650 22 $aGenomics.$0https://id.nlm.nih.gov/mesh/D023281
700 1 $aShaw, Karen Joy.$0http://id.loc.gov/authorities/names/n2002132883
830 0 $aInfectious disease (Totowa, N.J.)$0http://id.loc.gov/authorities/names/n99803805
852 00 $boff,hsl$hQH434$i.P384 2002